Gastrointestinal stromal tumor (GIST) is a rare cancer affecting the digestive tract or nearby structures within the abdomen.
Because GIST is a rare cancer, we provide ways for GIST patients to become savvy about their disease and their options for medical care.
There are many ways to join our active community of patients, caregivers and professionals.
Our listserv, phone pals program, facebook group, and GIST Summits provide avenues for fellow GISTers to connect and share experiences.
Press Release for the NCCN Guidelines update and the Breakthrough Therapy Designation for Ripretinib
GSI sets up Lee Ann Lamb Memorial fund for research
Qinlock (Ripretinib) and the INVICTUS and INTRIGUE trials
GIST Support International Summit 2021
Crenolanib ARO-O2 Trial Results
News from the 17th NIH Wild Type/Pediatric GIST Clinic
FDA accepts Blueprint Medicines’ NDA for PDGFRA Exon 18 Mutant GIST and Fourth-Line GIST
Blueprint trial Avapritinib vs Regorafenib
MutationMatters – a Blueprint educational resource
Deciphera makes a generous donation to GSI
Navigator Trial results (Avapritinib)